Stay at the forefront of antiplatelet drug (APD) management with this comprehensive review of global clinical updates and guidelines. This course critically synthesizes the latest evidence from major trials, international consensus documents, and national society recommendations, helping you navigate the complex and rapidly evolving APD landscape. We will dissect crucial topics like optimal DAPT duration post-PCI/ACS, the role of novel P2Y12 inhibitors, and strategies for managing patients requiring triple therapy. This is essential training for clinicians making high-stakes decisions in a field where evidence is constantly shifting.